Revision as of 21:50, 30 August 2011 editBogBot (talk | contribs)Bots53,132 edits populated new fields in {{drugbox}} and reordered per bot approval. Report errors and suggestions to User_talk:BogBot← Previous edit | Revision as of 22:00, 30 August 2011 edit undoCheMoBot (talk | contribs)Bots141,565 edits Updating {{drugbox}} (no changed fields - added verified revid - updated 'DrugBank_Ref', 'ChEBI_Ref', 'ChEBI_Ref') per Chem/Drugbox validation (report errors or bugs)Next edit → | ||
Line 1: | Line 1: | ||
{{Unreferenced stub|auto=yes|date=December 2009}} | {{Unreferenced stub|auto=yes|date=December 2009}} | ||
{{Drugbox | {{Drugbox | ||
| verifiedrevid = |
| verifiedrevid = 415529194 | ||
| IUPAC_name = 1-cyclohexylaminopropan-2-yl benzoate | | IUPAC_name = 1-cyclohexylaminopropan-2-yl benzoate | ||
| image = Hexylcaine.PNG | | image = Hexylcaine.PNG | ||
Line 24: | Line 24: | ||
| ATC_supplemental = | | ATC_supplemental = | ||
| PubChem = 10770 | | PubChem = 10770 | ||
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} | |||
| DrugBank = APRD01014 | | DrugBank = APRD01014 | ||
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} | | ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
Revision as of 22:00, 30 August 2011
This article does not cite any sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Hexylcaine" – news · newspapers · books · scholar · JSTOR (December 2009) (Learn how and when to remove this message) |
Clinical data | |
---|---|
ATC code |
|
Pharmacokinetic data | |
Elimination half-life | <10 minutes |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C16H23NO2 |
Molar mass | 261.359 g/mol g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(verify) |
Hexylcaine hydrochloride, also called cyclaine (Merck) or osmocaine, is a short-acting local anesthetic. It acts by inhibiting sodium channel conduction. Overdose can lead to headache, tinnitus, numbness and tingling around the mouth and tongue, convulsions, inability to breathe, and decreased heart function.
Local anesthetics (primarily sodium channel blockers) (N01B) | |||||||
---|---|---|---|---|---|---|---|
Esters by acid |
| ||||||
Amides | |||||||
Combinations | |||||||
|
This drug article relating to the nervous system is a stub. You can help Misplaced Pages by expanding it. |